NEW YORK (GenomeWeb) – Intrexon today priced a public offering of almost 4.9 million shares of its common stock aimed at raising $200 million in gross proceeds.
The Germantown, Maryland-based synthetic biology firm is offering 4,878,049 shares of its stock at $41 per share. Proceeds from the offering will go toward general corporate purposes and strategic acquisitions or investments, it said.
JMP Securities is the sole book-running manager while Stifel is the lead manager on the offering. Griffin Securities and Wunderlich Securities are the co-managers. Intrexon has granted the underwriters a 30-day option to purchase up to an additional 731,707 shares.
In afternoon trading, Intrexon shares rose 8 percent on the New York Stock Exchange to $45.94.